title: Diversity of neuronal inhibition: a path to novel treatments for neuropsychiatric disorders.
authors.affiliation: Laboratory of Genetic Neuropharmacology, McLean Hospital, Belmont, Massachusetts2Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.
authors.forename: Rebecca S
authors.initials: RS
authors.lastname: Benham
authors.affiliation: Laboratory of Genetic Neuropharmacology, McLean Hospital, Belmont, Massachusetts2Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.
authors.forename: Elif
authors.initials: E
authors.lastname: Engin
authors.affiliation: Laboratory of Genetic Neuropharmacology, McLean Hospital, Belmont, Massachusetts2Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.
authors.forename: Uwe
authors.initials: U
authors.lastname: Rudolph
mesh_terms: D000818:Animals; D001007:Anxiety / Q000503:physiopathology; D001321:Autistic Disorder / Q000188:drug therapy / Q000503:physiopathology; D003863:Depression / Q000188:drug therapy / Q000503:physiopathology; D058787:GABA-A Receptor Antagonists / Q000627:therapeutic use; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy* / Q000503:physiopathology; D011963:Receptors, GABA-A / Q000187:drug effects* / Q000502:physiology; D012559:Schizophrenia / Q000188:drug therapy / Q000503:physiopathology; D019966:Substance-Related Disorders / Q000188:drug therapy / Q000503:physiopathology
chemical_list: D058787:GABA-A Receptor Antagonists; D011963:Receptors, GABA-A